tsla

Biogen Stock Up On Buyback, Bull Note

A price-target hike from Jefferies is also helping BIIB

Managing Editor
Dec 20, 2019 at 10:09 AM
facebook X logo linkedin


The shares of Biogen Inc (NASDAQ:BIIB) are up 0.9% to trade at $300.18 this morning, after the drugmaker announced a $5 billion share repurchase program. This is the second $5 billion stock buyback Biogen has issued in 2019. Also fueling today's price action is a price-target hike from Jefferies $325 from $310, territory not charted since March. 

Despite today's upside move, Biogen stock remains stuck below year-to-date breakeven level. But the shares are still up 28% this quarter, thanks to a huge October bull gap in response to upbeat results from the company's Alzheimer Disease treatment

The majority of analysts are entrenched in the bearish camp, with 17 of the 25 in coverage doling out "hold" or worse ratings. Plus, the consensus 12-month price target of $303.29 is in line to its current perch. In other words, a shift in analyst attention could provide short-term tailwinds for the equity.

Options are an intriguing vehicle to bet on Biogen. The stock's Schaeffer's Volatility Index (SVI) of 26% sits in the 7th percentile of its annual range. This means the stock's short-term options are pricing in extremely low volatility expectations right now. 

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.